Cilengitide, an integrin antagonist, has shown potential in the treatment of malignant glioma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1589, 2007-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Merck KGaA's cilengitide, a vitronectin inhibitor designed to inhibit angiogenesis, has shown promise as a treatment for recurrent glioblastoma.

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The combination of imexon and dacarbazine has shown potential in patients with advanced malignant melanoma

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Oncolytic viruses for the treatment of malignant glioma

By Merrill Melinda K Selznick Lee A Gromeier Matthias

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 363-371

Informa Healthcare

Access to resources Recommend Favorite

Topical becocalcidiol has shown promise in the treatment of patients with chronic plaque psoriasis

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The Potential for Genetically Altered Microglia to Influence Glioma Treatment

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 750-762

Bentham Science Publishers

Access to resources Recommend Favorite